Published in Clin Immunol Immunopathol on May 01, 1984
Origins of anti-DNA autoantibodies. J Clin Invest (1985) 2.26
Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. J Clin Invest (1986) 2.00
A single germline VH gene segment of normal A/J mice encodes autoantibodies characteristic of systemic lupus erythematosus. J Exp Med (1986) 1.87
Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients. J Clin Invest (1985) 1.59
Homology of the NH2-terminal amino acid sequences of the heavy and light chains of human monoclonal lupus autoantibodies containing the dominant 16/6 idiotype. J Clin Invest (1985) 1.26
Five groups of antigenic determinants on DNA identified by monoclonal antibodies from (NZB X NZW)F1 and MRL/Mp-lpr/lpr mice. Immunology (1985) 1.20
Shared idiotypes are expressed on mouse and human anti-DNA autoantibodies. Immunology (1985) 1.15
Parallel sets of autoantibodies in MRL-lpr/lpr mice. An anti-DNA, anti-SmRNP, anti-gp70 network. J Exp Med (1987) 1.08
Lupus nephritis: the central role of nucleosomes revealed. Am J Pathol (2008) 1.03
Human monoclonal antibodies to phenolic glycolipid-I derived from patients with leprosy, and production of specific anti-idiotypes. Immunology (1988) 1.01
Immunoreactivity of anti-streptococcal monoclonal antibodies to human heart valves. Evidence for multiple cross-reactive epitopes. Am J Pathol (1991) 0.99
Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids. Clin Exp Immunol (1988) 0.96
Annulate lamellae: comparison of antigenic epitopes of annulate lamellae membranes with the nuclear envelope. J Cell Biol (1988) 0.90
Effect of antibodies to double stranded DNA, purified from serum samples of patients with active systemic lupus erythematosus, on the glomerular mesangial cells. Ann Rheum Dis (1992) 0.89
Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect. Immunology (1995) 0.87
The expression of acidic ribosomal phosphoproteins on the surface membrane of different tissues in autoimmune and normal mice which are the target molecules for anti-double-stranded DNA antibodies. Immunology (1996) 0.85
Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1998) 0.83
Human vimentin autoantibodies preferentially interact with a peptide of 30kD mol. wt, located close to the amino-terminal of the molecule. Clin Exp Immunol (1985) 0.83
Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66. Autoimmunity (2010) 0.82
16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus. BMC Med (2013) 0.82
A monoclonal antibody to the surface membrane of human platelets which inhibits ristocetin- and collagen-induced platelet aggregation reacts with H1 histones of cell nuclei. Clin Exp Immunol (1987) 0.81
Description and partial characterization of a nucleolar RNA-associated autoantigen defined by a human monoclonal antibody. J Exp Med (1987) 0.81
Experimental allergic myositis: ultrastructural, histochemical, immunological and immunohistochemical studies. Acta Neuropathol (1987) 0.81
Systemic lupus erythematosus murine monoclonal DNA-binding antibodies recognize cytoplasmic and nuclear phosphorylated antigens that display cell cycle redistribution in HEp-2 cells. Immunology (1992) 0.81
Autoimmune mice make anti-Fc gamma receptor antibodies. J Exp Med (1990) 0.79
Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy. BMC Med (2013) 0.79
Serum monoclonal antibodies derived from patients with multiple myeloma react with mycobacterial phosphoinositides and nuclear antigens. Clin Exp Immunol (1989) 0.78
Oligonucleotide linked to human gammaglobulin specifically diminishes anti-DNA antibody formation in cultured lymphoid cells from patients with systemic lupus erythematosus. J Clin Invest (1988) 0.78
Age-related natural antibody specificities among hybridoma clones originating from NZB spleen. Immunology (1987) 0.77
Expression in systemic lupus erythematosus of an idiotype common to DNA-binding and nonbinding monoclonal antibodies produced by normal human lymphoid cells. J Clin Invest (1989) 0.76
Affinity of human carcinoma cell nuclei for polyinosinic acid demonstrated by monoclonal antibodies. Clin Exp Immunol (1986) 0.75
Generation of monoclonal anti-dermatan sulphate antibodies cross-reacting to calf thymus DNA. Clin Exp Immunol (1989) 0.75
Human monoclonal antibodies from patients with rheumatoid arthritis: cross reactions against cellular constituents. Clin Exp Immunol (1985) 0.75
Binding specificity of antiidiotypic autoantibodies to anti-DNA antibodies in humans. J Clin Invest (1988) 0.75
IgG binding of monoclonal anti-nuclear antibodies from MRL-lpr/lpr mice. Immunology (1990) 0.75
Antibodies to T- and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus. J Clin Invest (1992) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation (1995) 5.90
Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med (1981) 5.48
Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med (1983) 4.43
Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation (1996) 3.82
Negatively supercoiled plasmids contain left-handed Z-DNA segments as detected by specific antibody binding. Cell (1982) 3.80
Antibodies to left-handed Z-DNA bind to interband regions of Drosophila polytene chromosomes. Nature (1981) 3.69
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA (1997) 3.68
Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol (1998) 3.67
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med (1993) 3.61
Characterization of genomic poly(dT-dG).poly(dC-dA) sequences: structure, organization, and conformation. Mol Cell Biol (1984) 3.42
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
Immunosuppressive therapy. The relation between clinical response and immunologic competence. N Engl J Med (1967) 3.29
Racial profiling in medical research. N Engl J Med (2001) 3.25
T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol (1989) 3.10
Antibodies specific for left-handed Z-DNA. Proc Natl Acad Sci U S A (1981) 3.05
Vulnerable plaque: pathobiology and clinical implications. Ann Intern Med (1998) 3.04
Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum (1999) 2.99
Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96
Antigen-binding diversity and idiotypic cross-reactions among hybridoma autoantibodies to DNA. J Immunol (1981) 2.83
Pathology of acute and chronic coronary stenting in humans. Circulation (1999) 2.78
Hybridoma autoantibodies to DNA. J Immunol (1980) 2.76
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum (2002) 2.75
Jumping genes. N Engl J Med (1995) 2.69
Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol (1995) 2.69
Rheumatology in Israel. Br J Rheumatol (1996) 2.66
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53
Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med (2001) 2.52
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 2.49
Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice. J Exp Med (1980) 2.38
An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein. N Engl J Med (1980) 2.32
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum (2000) 2.28
Origins of anti-DNA autoantibodies. J Clin Invest (1985) 2.26
Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation (2001) 2.26
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol (2000) 2.26
Production of autoantibodies by human-human hybridomas. J Clin Invest (1982) 2.22
The immunoglobulin sequence. I. Arrest by 6-mercaptopurine and restitution by antibody, antigen or splenectomy. J Immunol (1965) 2.18
Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ (2008) 2.16
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med (1973) 2.15
Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol (1998) 2.12
Mixed connective tissue disease--goodbye to all that. Br J Rheumatol (1992) 2.11
Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J Exp Med (1987) 2.09
Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest (1996) 2.09
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med (1988) 2.09
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09
Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group. N Engl J Med (1993) 2.09
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
A high frequency idiotypic marker of anti-DNA autoantibodies in MRL-Ipr/Ipr mice. J Immunol (1982) 2.05
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int (1992) 2.01
Noninvasive evaluation of a novel swine model of renal artery stenosis. J Am Soc Nephrol (1999) 1.96
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) (2001) 1.96
Rabbit antibodies to histone fractions as specific reagents for preparative and comparative studies. J Biol Chem (1970) 1.93
Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation (1996) 1.92
Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder. Science (1965) 1.92
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A (1988) 1.91
Immunoregulation, oncogenic viruses, and malignant lymphomas. Lancet (1972) 1.90
Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol (1995) 1.89
A single germline VH gene segment of normal A/J mice encodes autoantibodies characteristic of systemic lupus erythematosus. J Exp Med (1986) 1.87
Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. N Engl J Med (1979) 1.87
Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation (1998) 1.87
Responsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol (1984) 1.85
Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc Natl Acad Sci U S A (1972) 1.85
Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann Rheum Dis (1989) 1.85
Exercise: effects on physical functional performance in independent older adults. J Gerontol A Biol Sci Med Sci (1999) 1.83
Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8- T helper cell lines that express the gamma delta T-cell antigen receptor. Proc Natl Acad Sci U S A (1990) 1.83
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) (2005) 1.83
High resolution detection of DNA-RNA hybrids in situ by indirect immunofluorescence. Nature (1977) 1.82
The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. J Clin Invest (1967) 1.82
Termination of the respiratory burst in human neutrophils. J Clin Invest (1978) 1.80
The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol (1992) 1.79
Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab (2005) 1.78
Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A (1991) 1.77
The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ Res (2000) 1.75